| Model Number |
6L45-21 |
| Medical Device Problem Code |
Low Test Results (2458)
|
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
10/27/2020
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
A review of tickets determined that there is normal complaint activity for architect total bilirubin reagent ln 6l45-21/lot number 56889uq02.Return testing was not completed as returns were not available.The tracking and trending review determined no trends were identified for discrepant patient results for the product.Worldwide data was reviewed and determined that the patient median result for total bilirubin reagent lot number 56889uq02 is within established control limits.Retesting of the samples gave expected normal results.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue was adequately addressed.Based on the investigation, no systemic issue or deficiency of the architect total bilirubin reagent lot number 56889uq02 was identified.
|
| |
|
Event or Problem Description
|
|
The customer reported false decreased total bilirubin results for 2 patient samples while running on the architect c8000 processing module.The following data was provided on (b)(6) 2020 (reference range: 0.2-1.2 mg/dl): sample 1 = initial = 0.13 mg/dl; repeat result = 0.74 mg/dl.Sample 2 = initial = <0.10 mg/dl; repeat result = 0.94 mg/dl there was no impact to patient management reported.
|
| |
|
Search Alerts/Recalls
|